1Greager M.Hemadynamic and neurohumoral rersonse to exercise in patients with congestive heart failuretreated with Captopril.Br Heare J,1986,53(4):431.
2Magnani B.Captopril in mild heart faiure prelimnary observations of a long term,doublelind,placebo-controlled mul-ticenter trial.postgarad Med J,1986,62(suppl):153.
3Drexler H,et al.Contrasting Peripheral short-term and long-term effects of converting enzyme in hibition in patients With congestive heart failure adouble-blind placebo-controlles trial Circulation,1989,79:491.
8Tasaka S, Koh H, Yamada W, et al.Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632[J].Am J Respir Cell Mol Biol, 2005, 32(6):504-510.
9Lu B, Yu L, Li S, et al.Alleviation of CCl4-induced cirrhosis in rats by tetramethylpyrazine is associated with downregulation of leptin and TGF-β1 pathway[J].Drug Chem Toxicol, 2010, 33(3):310-315.
10Mei D, Mao S, Sun W, et al.Effect of chitosan structure properties and molecular weight on the intranasal absorption of te-tramethylpyrazine phosphate in rats[J].Eur J Pharm Biopharm, 2008, 70(3):874-881.
